Gapping down on weak earnings/guidance: NTAP -17.7%, NWY -7.7%, CA -6.1%, SNPS -6.0% (also downgraded at HSBC), MYL -4.5%, ZUMZ -4.3%... Other news: XRTX -8.4% (down in sympathy with NTAP, which makes up ~50% of XRTX revs), ONT -5.2% (continued profit taking following yesterday's reversal), BRLC -4.6% (prices 25.6 mln share offering at $5.75/share), ESLR -3.2% (prices a 15 mln share common stock offering at $8.25/share), DLB prices a 7 mln share common stock offering at $32/share), BRCD -2.0% (down in sympathy with NTAP). DNDN -2.3% (downgraded at JMP Securities).
Gapping up on strong earnings/guidance: SAFM +16.3%, OVEN +8.6%, GYMB +8.5%, PACT +8.0%... Other news: MITI +42.0% (co and Nycomed enter into exclusive worldwide collaboration to develop and commercialize anti-GM-CSF antibodies), LJPC +33.5% (reports Riquent well tolerated in three studies at International Lupus Congress), YMI +10.0% (reports successful regulatory reviews of nimotuzumab manufacturing), TASR +7.0% (announces three domestic orders and one export order), EXEL +5.9% (files IND application for XL019), GLS +4.4% (mentioned positively by Cramer), VOD +2.4% (continuation of yesterday's strength).
No comments:
Post a Comment